Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marlene Carmo

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Current Gene Therapy|September 24, 2014
Gene therapy for haemophagocytic lymphohistiocytosisClaire Booth, Marlene Carmo, H Bobby Gaspar
The Journal of Gene Medicine|April 13, 2007
Scaleable purification process for gene therapy retroviral vectorsTeresa Rodrigues, Andreia Carvalho, Marlene Carmo, et al.
Biotechnology Progress|April 8, 2006
Screening of novel excipients for improving the stability of retroviral and adenoviral vectorsPedro E Cruz, Ana Carina Silva, António Roldão, et al.
Human Gene Therapy|July 30, 2016
High Level of Perforin Expression Is Required for Effective Correction of Hemophagocytic LymphohistiocytosisSwati Tiwari, Adrianne Hontz, Catherine E Terrell, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 19, 2011
Manufacturing of retrovirusesPedro E Cruz, Teresa Rodrigues, Marlene Carmo, et al.
The Journal of Gene Medicine|June 10, 2009
Stabilization of gammaretroviral and lentiviral vectors: from production to gene transferMarlene Carmo, Ana Alves, Ana Filipa Rodrigues, et al.
The Journal of Allergy and Clinical Immunology|January 23, 2018
T-cell gene therapy for perforin deficiency corrects cytotoxicity defects and prevents hemophagocytic lymphohistiocytosis manifestationsSujal Ghosh, Marlene Carmo, Miguel Calero-Garcia, et al.
The Journal of Allergy and Clinical Immunology|August 15, 2016
Mutations in linker for activation of T cells (LAT) lead to a novel form of severe combined immunodeficiencyChiara Bacchelli, Federico A Moretti, Marlene Carmo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 20, 2014
Perforin gene transfer into hematopoietic stem cells improves immune dysregulation in murine models of perforin deficiencyMarlene Carmo, Kimberly A Risma, Paritha Arumugam, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 22, 2012
The β-globin locus control region in combination with the EF1α short promoter allows enhanced lentiviral vector-mediated erythroid gene expression with conserved multilineage activityClaudia A Montiel-Equihua, Lin Zhang, Sean Knight, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Current Gene Therapy|September 24, 2014
Gene therapy for haemophagocytic lymphohistiocytosisClaire Booth, Marlene Carmo, H Bobby Gaspar
The Journal of Gene Medicine|April 13, 2007
Scaleable purification process for gene therapy retroviral vectorsTeresa Rodrigues, Andreia Carvalho, Marlene Carmo, et al.
Biotechnology Progress|April 8, 2006
Screening of novel excipients for improving the stability of retroviral and adenoviral vectorsPedro E Cruz, Ana Carina Silva, António Roldão, et al.
Human Gene Therapy|July 30, 2016
High Level of Perforin Expression Is Required for Effective Correction of Hemophagocytic LymphohistiocytosisSwati Tiwari, Adrianne Hontz, Catherine E Terrell, et al.
Methods in Molecular Biology (Clifton, N.J.)|May 19, 2011
Manufacturing of retrovirusesPedro E Cruz, Teresa Rodrigues, Marlene Carmo, et al.
The Journal of Gene Medicine|June 10, 2009
Stabilization of gammaretroviral and lentiviral vectors: from production to gene transferMarlene Carmo, Ana Alves, Ana Filipa Rodrigues, et al.
The Journal of Allergy and Clinical Immunology|January 23, 2018
T-cell gene therapy for perforin deficiency corrects cytotoxicity defects and prevents hemophagocytic lymphohistiocytosis manifestationsSujal Ghosh, Marlene Carmo, Miguel Calero-Garcia, et al.
The Journal of Allergy and Clinical Immunology|August 15, 2016
Mutations in linker for activation of T cells (LAT) lead to a novel form of severe combined immunodeficiencyChiara Bacchelli, Federico A Moretti, Marlene Carmo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 20, 2014
Perforin gene transfer into hematopoietic stem cells improves immune dysregulation in murine models of perforin deficiencyMarlene Carmo, Kimberly A Risma, Paritha Arumugam, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 22, 2012
The β-globin locus control region in combination with the EF1α short promoter allows enhanced lentiviral vector-mediated erythroid gene expression with conserved multilineage activityClaudia A Montiel-Equihua, Lin Zhang, Sean Knight, et al.
Pageof 2